Brain Cancer Epidemiology Forecast 2025-2034

In 2023, brain cancer ranked as the 10th leading cause of cancer death for both men and women across all age groups. It was estimated that around 94,390 individuals in the United States will be diagnosed with a new primary brain tumor in 2023, with the median age at diagnosis reported to be 61 years.

Brain Cancer Epidemiology Forecast Report Coverage

The “Brain Cancer Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of brain cancer. It projects the future incidence and prevalence rates of brain cancer across various populations. The study covers age, gender, and type as major determinants of the brain cancer-affected population. The report highlights patterns in the prevalence of brain cancer over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of brain cancer in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Brain Cancer Disease Overview

Brain cancer is defined as the abnormal growth of cells within the brain or surrounding tissues. The formation of tumors in the brain can impact normal brain functions, such as cognition, movement, and sensory processing. Primary brain tumors originate in the brain or nearby tissues whereas secondary (metastatic) brain tumors are a result of cancer cells that spread to the brain from other parts of the body, such as the lungs, breasts, or kidneys. Common symptoms include nausea, persistent headaches, vision or hearing changes, and cognitive or behavioral changes, among others.

Brain Cancer: Treatment Overview

The type, location, and size of the tumor, along with the patient’s overall health is taken into consideration while creating a treatment plan for brain cancer. Surgery is often the first line of treatment and helps in reducing tumor size and relieving symptoms. Craniotomy or minimally invasive techniques are used to remove as much of the tumor as possible without impacting brain function. Radiation therapy such as external beam radiation therapy (EBRT) and stereotactic radiosurgery (SRS) also help in destroying cancer cells or shrinking tumors using high-energy beams.

Epidemiology

The brain cancer epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for brain cancer by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for brain cancer and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• The age-adjusted rate of new brain and nervous system cancer cases was 6.2 per 100,000 people, and the death rate was 4.4 per 100,000, based on data from 2017-2021 and deaths from 2018-2022.
• According to the American Cancer Society, the risk of developing a malignant brain or spinal cord tumor in an individual in their lifetime is estimated to be less than 1%, with the survival rates varying widely depending on the type of tumor and other factors.
• Studies show that around 3.9% of all brain tumor cases are diagnosed in children aged 0-14 years, with pilocytic astrocytomas, embryonal tumors, and other gliomas considered the most common brain tumor types in this age group.
• Brain tumor incidence is higher in females (58.7%) than in males (41.3%). Non-malignant brain tumors are more prevalent in females (64.4%) than in males (35.6%), while malignant brain tumors are more prevalent in males (55.8%) than in females (44.2%).

Country-wise Brain Cancer Epidemiology

The brain cancer epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of brain cancer varies between countries owing to differences in factors such as genetic predispositions, exposure to carcinogens, such as radiation or industrial toxins, prevalence of infections linked to cancer risk, age distribution, and access to healthcare, among others. According to the American Cancer Society, around 25,400 malignant brain or spinal cord tumors are estimated to be diagnosed in the United States in 2023. This covers both adults and children and includes about 14,420 cases in males and 10,980 in females.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of brain cancer based on several factors.
• Brain Cancer Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of brain cancer are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of brain cancer epidemiology in the 8 major markets?
• What will be the total number of patients with brain cancer across the 8 major markets during the forecast period?
• What was the country-wise prevalence of brain cancer in the 8 major markets in the historical period?
• Which country will have the highest number of brain cancer patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of brain cancer during the forecast period of 2025-2034?
• What are the currently available treatments for brain cancer?
• What are the disease risks, signs, symptoms, and unmet needs of brain cancer?

This product will be delivered within 3-5 business days.